217 related articles for article (PubMed ID: 31081240)
1. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
[TBL] [Abstract][Full Text] [Related]
2. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
3. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
[TBL] [Abstract][Full Text] [Related]
4. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
5. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
6. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.
Zhang L; Wang J; Xu L; Zhou J; Guan X; Jiang F; Wu Y; Fan W
Mutagenesis; 2012 Jan; 27(1):67-76. PubMed ID: 22002622
[TBL] [Abstract][Full Text] [Related]
8. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.
Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY
Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132
[TBL] [Abstract][Full Text] [Related]
9. Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis.
Ma YJ; Feng SC; Hu SL; Zhuang SH; Fu GH
Asian Pac J Cancer Prev; 2014; 15(15):6071-4. PubMed ID: 25124575
[TBL] [Abstract][Full Text] [Related]
10. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
11.
Li B; Shi X; Yuan Y; Peng M; Jin H; Qin D
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752341
[TBL] [Abstract][Full Text] [Related]
12. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
Yang Z; Fang X; Pei X; Li H
Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
[TBL] [Abstract][Full Text] [Related]
14. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
15. Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population.
Wu X; Lu W; Jiang C; Zhang D; Zhang W; Cui Y; Zhuo Z; Mei H; Wang Y; Zhang M; Chen S
PLoS One; 2023; 18(5):e0284825. PubMed ID: 37141338
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
18. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
